Legal & General Group’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Sell |
123,239
-18,436
| -13% | -$579K | ﹤0.01% | 1664 |
|
|
2025
Q1 | $4.2M | Buy |
141,675
+4,800
| +4% | +$142K | ﹤0.01% | 1608 |
|
|
2024
Q4 | $4.04M | Buy |
136,875
+20,163
| +17% | +$595K | ﹤0.01% | 1682 |
|
|
2024
Q3 | $3.63M | Sell |
116,712
-3,805
| -3% | -$118K | ﹤0.01% | 1719 |
|
|
2024
Q2 | $4.08M | Buy |
120,517
+84,472
| +234% | +$2.86M | ﹤0.01% | 1624 |
|
|
2024
Q1 | $2.34M | Sell |
36,045
-250
| -0.7% | -$16.3K | ﹤0.01% | 1873 |
|
|
2023
Q4 | $2.48M | Buy |
36,295
+8,609
| +31% | +$588K | ﹤0.01% | 1844 |
|
|
2023
Q3 | $1.44M | Buy |
27,686
+3,712
| +15% | +$193K | ﹤0.01% | 2044 |
|
|
2023
Q2 | $1.44M | Buy |
23,974
+17,920
| +296% | +$1.07M | ﹤0.01% | 2071 |
|
|
2023
Q1 | $299K | Buy |
6,054
+304
| +5% | +$15K | ﹤0.01% | 2450 |
|
|
2022
Q4 | $328K | Sell |
5,750
-9,599
| -63% | -$548K | ﹤0.01% | 2439 |
|
|
2022
Q3 | $719K | Sell |
15,349
-443
| -3% | -$20.8K | ﹤0.01% | 2246 |
|
|
2022
Q2 | $589K | Sell |
15,792
-6,577
| -29% | -$245K | ﹤0.01% | 2305 |
|
|
2022
Q1 | $667K | Hold |
22,369
| – | – | ﹤0.01% | 2322 |
|
|
2021
Q4 | $765K | Sell |
22,369
-2,908
| -12% | -$99.5K | ﹤0.01% | 2305 |
|
|
2021
Q3 | $933K | Buy |
25,277
+6,186
| +32% | +$228K | ﹤0.01% | 2265 |
|
|
2021
Q2 | $725K | Buy |
+19,091
| New | +$725K | ﹤0.01% | 2265 |
|